Chronic pain

Research from anesthesiology, pain and critical care journals, sourced from PubMed.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
RCT J Pain Published 11 Jul 2026
Acute pain impairs locomotor learning and retention in older adults.
AI-generated abstract summary · verify against the original paper
  • Randomized study of 30 younger and 30 older healthy adults learning an asymmetric walking pattern under either pain-free or acute capsaicin-heat pain conditions.
  • Learning used distorted visual step-length feedback to induce a 9% gait asymmetry during the learning phase.
  • Pain reduced learning (6.6% ± 0.4 vs 8.1% ± 0.5, p=0.02) and 24-hour retention (2.6% ± 0.7 vs 5.9% ± 0.7, p<0.01), while within-session retention was unaffected.
  • Older adults learned less than younger adults (F(1,59)=4.71, p=0.03), and the authors suggest pain may reduce the effectiveness of motor learning-based rehabilitation.
PubMed indexed 11 Jul 2026 Imported 9 Nov 2026 Jackson SR et al. Publisher Chronic pain
Article J Pain Published 11 Jul 2026
C-reactive protein and incident chronic pain in older adults: comorbidity-driven risk profiles and implications for preventive screening.
AI-generated abstract summary · verify against the original paper
  • This longitudinal analysis of 1,850 older adults from the Health and Retirement Study (2016-2022) followed people without chronic pain or arthritis at baseline.
  • Inflammatory markers (CRP, IL-6, IL-10, IGF-1, and a composite INFLA-score) were tested as exposures for first-reported incident chronic pain using Poisson models.
  • After adjustment, CRP was independently associated with incident chronic pain (IRR 1.10, 95% CI 1.01-1.20), but the effect was modest, while depression (IRR 1.52, 95% CI 1.23-1.88) was stronger.
  • Adding CRP to a clinical prediction model improved discrimination minimally (ΔAUC +0.009), and the authors conclude that comorbidity and psychosocial factors dominate risk over biomarker screening.
PubMed indexed 11 Jul 2026 Imported 9 Nov 2026 Rech L et al. Publisher Chronic pain
Article J Pain Published 10 Jul 2026
Association between preadolescent spinal pain and painful temporomandibular disorders and headache in young adulthood.
AI-generated abstract summary · verify against the original paper
  • This longitudinal analysis of the Danish National Birth Cohort included 9,639 participants with preadolescent spinal pain data, followed to adulthood for p-TMD and headache.
  • Spinal pain at age 11 (neck, middle back, low back) was graded by intensity and frequency, and moderate-to-severe or high-frequency pain was compared with none or mild pain.
  • Moderate-to-severe or high-frequency pain was linked to higher odds of p-TMD: neck OR 1.85 (95% CI 1.52-2.25), middle back OR 1.74 (1.37-2.21), low back OR 2.16 (1.64-2.85).
  • Headache showed similar associations (neck OR 1.81, middle back OR 1.55, low back OR 1.64), and the authors suggest early spinal pain may mark later vulnerability.
PubMed indexed 10 Jul 2026 Imported 9 Nov 2026 Mansoori M et al. Publisher Chronic painPediatric
RCT J Pain Published 10 Jul 2026
Reconsolidation blockade with propranolol as a novel treatment for fibromyalgia: A double-blind, randomized placebo-controlled feasibility study.
AI-generated abstract summary · verify against the original paper
  • Double-blind, randomized pilot feasibility study of 24 adults with fibromyalgia, excluding those with comorbid PTSD or propranolol contraindications.
  • Six weekly reconsolidation sessions with oral propranolol (40-80 mg) or placebo, with all participants also viewing pain-education videos.
  • Propranolol improved pain interference more than placebo after the last visit (p=.032) but not at 4-week follow-up; emotional functioning improved at follow-up (p=.006). Four participants withdrew and adverse events were mild and similar across groups.
  • The authors judged the approach feasible and recommended testing treatment effect in a larger trial.
PubMed indexed 10 Jul 2026 Imported 9 Nov 2026 Coulombe-Leveque A et al. Publisher Chronic pain
Observational Pain Published 10 Jul 2026
Understanding opioid use for noncancer pain: a community pharmacy-based observational study of patient profiles and experiences.
AI-generated abstract summary · verify against the original paper
  • This observational study surveyed 1048 Belgian community pharmacy patients using opioids for noncancer pain (64.4% female, mean age 59.0 years).
  • There was no intervention or comparator; a structured questionnaire described patient profiles, opioid initiation and follow-up, and treatment experiences.
  • Median pain intensity was 7 (IQR 2) on a 0-10 scale, nearly 30% received strong opioids, and about 40% attempted discontinuation, nearly half of them abruptly.
  • Opioids were most often started for chronic low back pain, perceived need was high, and the authors highlight gaps in counseling and follow-up.
PubMed indexed 10 Jul 2026 Imported 9 Nov 2026 Mehuys E et al. Publisher Chronic pain
Article Interv Pain Med Published 9 Jul 2026
Adverse events associated with basivertebral nerve radiofrequency ablation: A comprehensive analysis from the MAUDE database.
AI-generated abstract summary · verify against the original paper
  • Retrospective review of 96 unique FDA MAUDE device reports involving FDA-cleared basivertebral nerve ablation systems, with descriptive statistics only.
  • The exposure was BVNA procedures as reported to MAUDE, with no comparator group.
  • Vertebral compression fracture was the most reported event at 21.9% (21/96), with timing documented in 12 of 21 cases: 6 within 30 days and 6 beyond.
  • The authors state the data cannot establish incidence or causality, but they flag fracture and pain as the most represented post-market signals, and both deaths were linked to anesthesia events rather than the device.
PubMed indexed 20 Jul 2026 Imported 9 Nov 2026 Fischer A et al. Publisher Chronic pain
Meta-analysis Br J Anaesth Published 9 Jul 2026
Regional anaesthesia and chronic postsurgical pain: a systematic review and network meta-analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and network meta-analysis of 158 randomised trials with 18,794 participants comparing regional anaesthesia with no block for chronic postsurgical pain.
  • Analyses compared regional anaesthesia with no block and examined technique, timing and catheter versus single-injection delivery across surgery types.
  • Regional anaesthesia reduced chronic postsurgical pain incidence (RR 0.73, 95% CI 0.67-0.80), with effects reported up to 12 months, while opioid use did not differ significantly (RR 0.88, 95% CI 0.61-1.28).
  • Neuraxial techniques appeared more effective than peripheral techniques after thoracotomy and video-assisted thoracoscopic surgery, but certainty was low to very low, and surgery type, sex and baseline risk had no significant effect.
PubMed indexed 9 Jul 2026 Imported 9 Nov 2026 Taylor-Rowan M et al. Publisher Chronic pain
Article J Pain Published 9 Jul 2026
Clinical and non-clinical formulations of paclitaxel produce qualitatively and quantitatively different peripheral neuropathy in rats and mice.
AI-generated abstract summary · verify against the original paper
  • Preclinical study in male and female inbred mice and outbred rats testing a paclitaxel-induced neuropathy protocol, with mechanical, thermal and cold sensitivity measured by von Frey, Hargreaves and cold plate assays.
  • Compares a standard commercially available paclitaxel formulation against a clinical formulation used in patients.
  • The clinical formulation produced behavioral effects lasting about 3-4 weeks longer than the commercial formulation, with higher plasma drug exposure partly explaining the difference.
  • The authors conclude that formulation should be considered when designing neuropathy models and that the findings suggest the value of testing paclitaxel derivatives with milder or shorter neuropathic effects.
PubMed indexed 9 Jul 2026 Imported 9 Nov 2026 Giuvelis D et al. Publisher Chronic painPharmacology
Article J Pain Published 9 Jul 2026
Threats to social safety and pain: A global study.
AI-generated abstract summary · verify against the original paper
  • This cross-sectional study linked individual data from 253,659 adults in 67 countries (World Health Survey) with country-level structural stigma measures.
  • The authors compared interpersonal difficulties and structural stigma as predictors of pain severity, and tested whether stigma amplifies the interpersonal-difficulty effect.
  • Interpersonal difficulties were strongly associated with more severe pain across all models (ORs 1.32-1.78, all p < 0.001), while structural stigma alone was not (OR 1.08, p = 0.79).
  • Structural stigma significantly amplified the link between interpersonal difficulties and pain (interaction OR 1.25, p = 0.003), which the authors suggest may help explain inconsistent cross-national pain findings.
PubMed indexed 9 Jul 2026 Imported 9 Nov 2026 Baranik LE et al. Publisher Chronic pain
RCT Interv Pain Med Published 8 Jul 2026
High versus low-voltage pulsed radiofrequency of the suprascapular nerve for chronic shoulder pain: A randomized pilot clinical trial.
AI-generated abstract summary · verify against the original paper
  • Randomized, single-center, assessor-blinded pilot trial of 20 patients with chronic rotator cuff tendinopathy and refractory shoulder pain.
  • Compared suprascapular nerve pulsed radiofrequency at 100 V against the standard 45 V, with identical duration and temperature settings.
  • The 100 V group had larger pain reductions on VAS at 1 month (between-group difference 2.7 points; p = 0.011) and 6 months (2.46 points; p = 0.022), with a similar QuickDASH pattern.
  • The authors describe the efficacy findings as exploratory and needing larger controlled trials; no serious procedure-related adverse events were recorded.
PubMed indexed 19 Jul 2026 Imported 9 Nov 2026 Costa JRP et al. Publisher Chronic pain
Article Pain Published 7 Jul 2026
Peripheral kappa opioid receptors modulate cold hypersensitivity in a mouse model of chemotherapy-induced neuropathy.
AI-generated abstract summary · verify against the original paper
  • Preclinical mouse study of oxaliplatin-induced cold hypersensitivity, testing male and female mice with pharmacology and a conditional knockout of KORs in dorsal root ganglia.
  • Compared the KOR antagonist norbinaltorphimine (10 mg/kg i.p.) and the KOR agonist U50,488 (5 mg/kg i.p.), plus a peripherally restricted agonist and DRG-specific Oprk knockout mice.
  • Norbinaltorphimine attenuated oxaliplatin-induced cold hypersensitivity, and U50,488 increased cold-plate jumps at 3°C, an effect blocked by the antagonist; the abstract reports no effect sizes, CIs or p values.
  • The authors conclude that peripheral KORs in dorsal root ganglia modulate cold hypersensitivity in this chemotherapy model, and that DRG KOR knockout reduced both agonist-induced and oxaliplatin-induced cold responses.
PubMed indexed 6 Jul 2026 Imported 9 Nov 2026 Madasu MK et al. Publisher Chronic pain
Article J Pain Published 6 Jul 2026
Peer support for chronic pain on social media: A cross-sectional study on casual support interactions.
AI-generated abstract summary · verify against the original paper
  • This cross-sectional study surveyed 197 adults with chronic pain who were active in social media online health communities, with a qualitative component on how these communities could improve.
  • The exposure was received and perceived peer support from casual social media interactions, analyzed with a two-way interaction and related to pain-related distress.
  • Higher received and perceived support together were linked to lower pain interference (β = -.10, p = .027), fewer catastrophizing thoughts (β = -.10, p = .049), and retrospectively reported decreases in pain intensity (β = .13, p = .024).
  • Higher e-health literacy was positively associated with informational and emotional support obtained from social media (β = .22, p = .001), and participant accounts informed practical recommendations for these communities.
PubMed indexed 6 Jul 2026 Imported 9 Nov 2026 Necaise A et al. Publisher Chronic pain
Observational J Pain Published 6 Jul 2026
Applying an intersectional framework to characterize chronic pain disparities one year following traumatic spinal cord injury.
AI-generated abstract summary · verify against the original paper
  • Retrospective cohort of 3514 adults with traumatic spinal cord injury from the US Spinal Cord Injury Model Systems database, examining race/ethnicity, income, and education.
  • Compared pain severity and severe pain interference across combinations of social disadvantage, with models adjusted for demographic and injury characteristics.
  • Non-Hispanic Black, low-income, low-education participants had 2.43 points higher pain severity (95% CI 2.06-2.79) and 2.96-fold higher odds of severe pain interference (95% CI 2.15-4.07) than the most advantaged group.
  • Mobility, days out of the house, private insurance, and perceived health status significantly mediated these disparities, which the authors propose as modifiable intervention targets.
PubMed indexed 6 Jul 2026 Imported 9 Nov 2026 Fundaun J et al. Publisher Chronic pain
Article Pain Published 6 Jul 2026
Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study.
AI-generated abstract summary · verify against the original paper
  • Nationwide cohort of 794 patients with locally advanced or metastatic pancreatic cancer, drawn from the PACAP-PROM registry (2016-2023), with pain assessed by patient-reported questionnaire items.
  • Compared patients receiving cancer therapy (n=648) with those on best supportive care (n=146), and assessed chemotherapy's association with pain using mixed-effects logistic regression.
  • Patients on best supportive care reported more pain than those on cancer therapy (57% vs 38%, P = 0.029), and chemotherapy was associated with lower odds of higher pain severity (OR 0.51; 95% CI 0.37-0.70).
  • At baseline 54% to 78% reported pain with no difference between locally advanced and metastatic disease; the authors conclude pain is a persistent concern warranting routine assessment from diagnosis.
PubMed indexed 6 Jul 2026 Imported 9 Nov 2026 Van Diepen AE et al. Publisher Chronic pain
Observational Pain Published 6 Jul 2026
Neurobiology of the trigeminal ganglion in comparison to the dorsal root ganglion.
AI-generated abstract summary · verify against the original paper
  • This review compares the trigeminal ganglion (head and face) with the dorsal root ganglion (body) across anatomy, embryology, cell composition, and molecular features.
  • It also covers A/C fiber ratios, CNS connections, sympathetic sprouting, ectopic discharges, ion channel biophysics, and neuron-glia interactions.
  • The authors suggest these differences may explain why the same stimuli or treatments can produce different responses in craniofacial versus somatic pain.
  • They conclude that pain targets should be identified separately for each system and that craniofacial and somatic pain may need distinct therapeutic strategies.
PubMed indexed 6 Jul 2026 Imported 9 Nov 2026 Su S et al. Publisher Chronic pain
Meta-analysis Pain Published 30 Jun 2026
Efficacy and effectiveness of melatonin for the management of musculoskeletal pain: a systematic review and meta-analysis of placebo and active controlled trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 23 randomized trials (2,028 participants) in chronic or postoperative musculoskeletal pain.
  • Melatonin was compared with placebo and with active controls such as analgesics.
  • In chronic pain, melatonin did not beat placebo overall (MD -6.76/100, 95% CI -15.89 to 2.36), but a low-risk sensitivity analysis did (MD -10.04, 95% CI -17.68 to -2.39).
  • The authors call the benefits modest, with most estimates below minimal clinically important difference thresholds and low-to-moderate certainty evidence.
PubMed indexed 30 Jun 2026 Imported 9 Nov 2026 Wu K et al. Publisher Chronic pain
Article Pain Published 30 Jun 2026
Reward-induced endogenous pain inhibition scales with action-outcome certainty in humans.
AI-generated abstract summary · verify against the original paper
  • Healthy-volunteer study (n=30) using a probabilistic gambling task with reversal learning, where participants gambled for pain relief and to avoid pain punishment.
  • The task was used to examine how uncertainty about which actions lead to outcomes relates to endogenous pain modulation, analysed with a computational model.
  • Pain inhibition from winning pain relief increased as the certainty about which actions produced relief increased; no numerical effect sizes are given in the abstract.
  • The authors conclude that endogenous pain modulation may be sensitive to volatility and perceived uncertainty, and suggest relevance to behavioral changes in chronic pain.
PubMed indexed 29 Jun 2026 Imported 9 Nov 2026 Hubschmid F et al. Publisher Chronic pain
Article Pain Published 29 Jun 2026
Predictive socio-cultural factors of pain intensity, disability, and quality of life in patients with nonspecific musculoskeletal pain: a prospective cohort study.
AI-generated abstract summary · verify against the original paper
  • Prospective cohort of 1350 patients with nonspecific musculoskeletal pain attending Dutch primary care physiotherapy, followed at baseline and at 3, 6, and 12 months.
  • Socio-cultural factors such as education, migration background, employment, living situation, and language proficiency were tested as predictors and associations of pain intensity, disability, and quality of life using linear mixed models.
  • Unemployment, retirement, migration background, and non-native Dutch proficiency were associated with poorer outcomes over 12 months, while higher education was linked to lower pain and disability; the abstract reports no effect sizes or CIs.
  • Cross-validation showed large unexplained variability, so individual outcomes could not be predicted from these factors, though the authors suggest NSMSP is unequally distributed.
PubMed indexed 29 Jun 2026 Imported 9 Nov 2026 Annevelink R et al. Publisher Chronic pain
Article J Pain Published 28 Jun 2026
The role of the thalamic paraventricular nucleus-prelimbic cortex pathway in diabetes-associated mechanical allodynia and thermal hyperalgesia.
AI-generated abstract summary · verify against the original paper
  • This preclinical mouse study used streptozotocin-induced diabetes and examined glutamatergic neurons in the paraventricular thalamus (PVT) and prelimbic cortex (PrL) using photometry, optogenetics, and chemogenetics.
  • Diabetic mice showed mechanical allodynia to von Frey stimulation alongside increased PVT glutamatergic activity, and manipulating PVT neurons changed mechanical thresholds.
  • Chemogenetic modulation of PVT and PrL glutamatergic neurons similarly altered nociceptive thresholds, which the authors interpret as a PVT-PrL pathway contributing to painful diabetic neuropathy-like phenotypes.
PubMed indexed 28 Jun 2026 Imported 9 Nov 2026 Liu YJ et al. Publisher Chronic pain
Meta-analysis Pain Published 26 Jun 2026
Neurophysiological and psychophysical mechanisms associated with immersive virtual reality-induced hypoalgesia: a systematic review.
AI-generated abstract summary · verify against the original paper
  • Preregistered PRISMA systematic review of 28 studies with 1142 participants, 59% of whom were women.
  • Examined neurophysiological and psychophysical mechanisms of immersive VR-induced hypoalgesia, with 76% of participants exposed to experimentally induced pain.
  • Synthesis linked IVR hypoalgesia to increased activity in descending pain modulation nuclei, enhanced parasympathetic activity, and higher pain tolerance or thresholds.
  • Most studies (89.3%) assessed only immediate effects of a single session, and the authors call for causal designs, ideally mediation analyses.
PubMed indexed 25 Jun 2026 Imported 9 Nov 2026 Guerra-Armas J et al. Publisher Chronic pain
Article J Pain Published 26 Jun 2026
Terminology and core components of co-design intervention in chronic pain management: An international Delphi study.
AI-generated abstract summary · verify against the original paper
  • International three-round e-Delphi study with 117 panellists in round 1, 98 in round 2 and 92 in round 3, from 30 countries.
  • Panellists rated terminology and components on five-point Likert scales against a 75% agreement threshold, and open-ended barrier and strategy responses were analysed thematically.
  • "Co-design" had the highest percentage agreement among preferred terms, and twelve core components were identified, such as lived-experience engagement and person-centredness.
  • Barriers spanned resource, cultural, knowledge, interpersonal and system/policy domains, with matched strategies such as training, communication and supportive policy.
PubMed indexed 22 Jun 2026 Imported 9 Nov 2026 Gashaw M et al. Publisher Chronic pain
Article Pain Published 25 Jun 2026
Dissociable peripheral and central mechanisms of monoacylglycerol lipase inhibition on pain- and depression-related behaviors in a rat model of neuropathic pain.
AI-generated abstract summary · verify against the original paper
  • A rat spared nerve injury study combined behavioral testing of pain and depression-like states with in vivo single-unit recordings from DRG and mPFC neurons.
  • The monoacylglycerol lipase inhibitor MJN110 was given at several doses, and CB1 and CB2 receptor antagonists were used to probe the receptor mechanisms.
  • Higher doses (1-5 mg/kg) reduced mechanical and cold hypersensitivity via peripheral CB1 receptors on DRG neurons, while both high and low doses reversed depression-like behaviors.
  • CB1 receptor blockade abolished both antidepressant and antinociceptive effects, whereas CB2 blockade had minimal effect on antinociception, and low-dose MJN110 normalized suppressed mPFC firing.
PubMed indexed 25 Jun 2026 Imported 9 Nov 2026 Chao D et al. Publisher Chronic pain
Article Interv Pain Med Published 24 Jun 2026
Volumetric analysis of cervical intervertebral discs: Reference values for interventional cervical disc procedures.
AI-generated abstract summary · verify against the original paper
  • Retrospective 10-year study of 135 cervical discs from discograms, excluding discs with epidural, vascular, or prevertebral extravasation.
  • Injected volumes were recorded and compared across cervical levels and between pain-positive and pain-negative discs.
  • Mean injected volume was 0.24 ± 0.10 mL (range 0.10–0.60 mL), with no significant differences across cervical levels.
  • Pain-positive discs had higher injected volumes than pain-negative discs at C3/4 through C6/7 (p < 0.05), and the authors suggest these values could guide injection volumes.
PubMed indexed 2 Jul 2026 Imported 9 Nov 2026 Sultan W et al. Publisher Chronic pain
Article Pain Published 24 Jun 2026
Trajectories of pain and cognitive function: 22 years of evidence in mid-to-later life.
AI-generated abstract summary · verify against the original paper
  • Observational cohort analysis of 19,376 English Longitudinal Study of Ageing participants followed over 11 waves across more than 20 years, using latent growth curve modelling.
  • Pain severity was rated at each wave on a 4-point scale (none, mild, moderate, severe) and cognition was measured with three objective tests.
  • Worsening pain was linked to faster cognitive decline when adjusted for age and sex (β = -0.053, P = 0.039), but this was not significant after full adjustment (β = -0.025, P = 0.365).
  • Higher initial pain severity remained associated with steeper cognitive decline in the fully adjusted model (β = -0.104, P < 0.001), suggesting baseline pain rather than change in pain is the relevant signal.
PubMed indexed 25 Jun 2026 Imported 9 Nov 2026 Andres S et al. Publisher Chronic pain
RCT Pain Published 24 Jun 2026
Neurofeedback of somatosensory alpha oscillations modulates sensory and affective pain through dissociable neurocognitive pathways.
AI-generated abstract summary · verify against the original paper
  • Double-blind, sham-controlled trial in 80 healthy participants receiving neurofeedback training during capsaicin-induced tonic pain.
  • Real feedback rewarded contralateral somatosensory alpha power, while sham feedback was noncontingent; pain ratings and EEG microstates were tracked.
  • Real feedback raised targeted alpha power and reduced pain unpleasantness early and sustained, with a later, block-specific drop in intensity; the abstract gives no effect sizes or p-values.
  • The authors conclude that alpha neurofeedback mainly modulates affective pain, via dissociable neurocognitive pathways, and suggest it may be a nonpharmacological option.
PubMed indexed 25 Jun 2026 Imported 9 Nov 2026 Zheng Q et al. Publisher Chronic painNeuro
Article Pain Published 24 Jun 2026
No effect of rhythmic visual stimulation on experimental pain perception.
AI-generated abstract summary · verify against the original paper
  • Two within-participant experiments tested rhythmic visual stimulation: experiment 1 enrolled 41 participants with thermal pain and EEG, and experiment 2 enrolled 49 new participants with electrical or laser pain.
  • Participants received brief (13 s) RVS at 10, 18, or 42 Hz or an arrhythmic control in experiment 1, and 10-minute RVS at 10 Hz or a 1 Hz control in experiment 2.
  • RVS successfully increased EEG oscillations at the targeted frequencies, but pain-evoked oscillatory responses and acute pain ratings did not change in either experiment.
  • Bayesian analyses gave strong evidence for the null hypothesis, and the authors suggest RVS effects on pain may be less robust or more context-dependent than previously proposed.
PubMed indexed 25 Jun 2026 Imported 9 Nov 2026 Roy N et al. Publisher Chronic painPediatric
Article Interv Pain Med Published 22 Jun 2026
Successful long-term palliative pain management using an intrathecal catheter adapted as a lumbar drain connected to an external infusion pump: A case report.
AI-generated abstract summary · verify against the original paper
  • Single-patient case report of a 54-year-old man with refractory pain from sacral metastasis of rectosigmoid adenocarcinoma.
  • A lumbar drain catheter, tunneled and connected to an external ambulatory pump, delivered a bupivacaine and fentanyl infusion.
  • Pain relief lasted 66 days, with a 50% reduction in pain scores and a 30% reduction in systemic opioid requirements.
  • The authors report better sleep, elimination of frequent ER visits and admissions, and no catheter infection or dislodgement, and conclude the approach is feasible in selected patients.
PubMed indexed 29 Jun 2026 Imported 9 Nov 2026 Riziq MG et al. Publisher Chronic pain
Article Pain Published 22 Jun 2026
Vasopressin 1A and 1B receptor-mediated antinociception in a mouse model of cortical spreading depolarization.
AI-generated abstract summary · verify against the original paper
  • Preclinical study in male and female Thy1-ChR2-YFP mice, using optogenetically induced cortical spreading depolarization (opto-SD) as a model of migraine with aura.
  • Mice received the vasopressin 1A antagonist relcovaptan, the vasopressin 1B antagonist nelivaptan, or vehicle right after opto-SD, then were tested for periorbital allodynia, grimace, photosensitivity, and locomotion.
  • Opto-SD lowered periorbital mechanical thresholds, which recovered by 4 hours; both antagonists blocked that recovery, but neither changed grimace, photosensitivity, or locomotion.
  • The authors conclude that endogenous vasopressinergic receptor activation is analgesic in this model, and opto-SD increased activation of paraventricular neurons that stained for vasopressin or oxytocin.
PubMed indexed 25 Jun 2026 Imported 9 Nov 2026 Kwamo T et al. Publisher Chronic pain
Article Pain Published 22 Jun 2026
Duration of clinically meaningful improvement in pain as a patient-centered endpoint in acute pain trials.
AI-generated abstract summary · verify against the original paper
  • Retrospective reanalysis of 34 phase 2 and 3 acute analgesic trials submitted to the FDA (N = 11,028) comparing the standard SPID endpoint with a new endpoint, ROOT.
  • ROOT is the share of study time with at least 50% pain reduction and no recent rescue or early discontinuation, with participants counted as nonresponders for 6 hours after rescue.
  • The two endpoints reached statistically concordant conclusions for 92.2% of 204 treatment comparisons; LOCF imputation covered a median of 27% of study time in active groups and 46% in placebo.
  • The authors report that LOCF distorted the temporal pattern of treatment effects during high rescue use, and that ROOT detects significant effects with similar ability to SPID.
PubMed indexed 19 Jun 2026 Imported 9 Nov 2026 Miller CJ et al. Publisher Chronic pain
Article J Pain Published 20 Jun 2026
Spontaneously hypertensive rats exhibit reduced facial pain sensitivity with altered electrophysiology and transcriptomics in the trigeminal ganglia.
AI-generated abstract summary · verify against the original paper
  • Preclinical study comparing male spontaneously hypertensive rats with normotensive Wistar-Kyoto controls, using operant facial pain assays, trigeminal ganglion electrophysiology, and bulk RNA sequencing.
  • The exposure is the rat strain, so the comparison is genetic background (hypertensive versus normotensive) rather than a treatment.
  • SHRs showed reduced thermal and mechanical facial pain sensitivity, but measured systolic blood pressure did not robustly explain the thermal difference; the abstract reports no effect sizes or p values.
  • SHRs had larger HCN and voltage-gated potassium currents and broadly lower ion channel gene expression, and the authors link these changes to reduced trigeminal nociception.
PubMed indexed 20 Jun 2026 Imported 9 Nov 2026 Donertas-Ayaz B et al. Publisher Chronic pain
Article J Pain Published 19 Jun 2026
Defining chronic low back pain: Should we include the number of pain days?
AI-generated abstract summary · verify against the original paper
  • This cross-sectional online survey of 353 adults with chronic low back pain examined how the number of weekly pain days relates to clinical characteristics.
  • Participants were grouped by weekly pain days (1-3, 4-6, or daily), and results were also compared using a dichotomized cut-off of four or more days.
  • Pain days were moderately associated with pain intensity and disability, and 50.8-67.2% of those with 2 or 3 pain days still had clinically relevant symptoms.
  • The authors suggest four or more days per week may be a meaningful cut-off, but it excludes a substantial subgroup with clinically relevant chronic low back pain.
PubMed indexed 19 Jun 2026 Imported 9 Nov 2026 Matheve T et al. Publisher Chronic pain
Article Pain Published 18 Jun 2026
Cortical disinhibition in peripheral neuropathy unveiled by exploratory analysis of spectral alterations in contact heat-evoked potential.
AI-generated abstract summary · verify against the original paper
  • Exploratory study of 48 peripheral neuropathy patients (29 painful, 19 painless) and 30 healthy controls, using multichannel EEG during contact heat-evoked potentials.
  • Spectral power of the heat-evoked potentials was modeled with FOOOF to estimate excitation-inhibition balance, tracking the spectral exponent and alpha-band changes across early and late poststimulus periods.
  • Only painful patients showed an attenuated poststimulus exponent increase in central and parietal areas, while both painful and painless groups showed alpha-band desynchronization across all three regions.
  • The authors interpret these changes as possible cortical disinhibition and an electrophysiological sign of central sensitization; a frontal exponent change was associated with more severe lower-limb skin nerve degeneration.
PubMed indexed 17 Jun 2026 Imported 9 Nov 2026 Lee CW et al. Publisher Chronic pain
Article J Pain Published 17 Jun 2026
Psychometric evaluation and discriminative validity of the Short-Form Brief Pain Inventory across nociceptive, neuropathic, and nociplastic pain mechanisms.
AI-generated abstract summary · verify against the original paper
  • Cross-sectional cohort of 666 adults, with clinician-assigned predominant pain mechanisms: 357 nociceptive, 125 neuropathic, and 184 nociplastic.
  • The Short-Form Brief Pain Inventory was evaluated for reliability, structural validity, and its ability to discriminate between mechanism groups using item patterns.
  • Internal consistency was excellent overall (Cronbach's α = 0.90, 95% CI 0.89-0.91), but discrimination was limited, with a highest multiclass AUC of 0.70.
  • A three-factor structure (severity, emotional interference, physical interference) held across all groups, and the authors advise against using the scale alone for mechanistic classification.
PubMed indexed 17 Jun 2026 Imported 9 Nov 2026 Steen JP et al. Publisher Chronic pain
Article J Pain Published 17 Jun 2026
Characterizing injury-related perceived threat trajectories after acute, isolated extremity injuries: A prospective cohort study.
AI-generated abstract summary · verify against the original paper
  • Prospective cohort of 138 adults with isolated extremity injuries, enrolled within three weeks of injury and followed to six months.
  • Group-based trajectory modelling tracked perceived threat, pain interference, and anxiety, depression, and PTSD symptoms, with logistic regression examining baseline predictors.
  • About 21% had stable high perceived threat, linked to severe-to-moderate pain interference but not consistently to distress. Higher baseline pain intensity (OR 1.46, 95% CI 1.13-1.90) and anxiety (OR 1.08, 95% CI 1.01-1.16) predicted this group.
  • The authors describe perceived threat as having both trait-like and dynamic features, and suggest persistently high threat may identify patients with more complex recovery.
PubMed indexed 17 Jun 2026 Imported 9 Nov 2026 Butler P et al. Publisher Chronic pain
Meta-analysis Pain Published 17 Jun 2026
Patterns of heart rate variability responses to acute skin-breaking procedures in neonates: a systematic review and meta-analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 32 studies (27 meta-analyzed, 5 narrative) in hospitalized preterm and full-term newborns within their first month of life.
  • The exposure of interest was acute skin-breaking painful procedures, with heart rate variability (HRV) patterns of pain-related stress reactivity and regulation as outcomes.
  • The authors report four themes: effects of gestational and postnatal age, variability across HRV measures, normative regulation patterns, and heterogeneity across HRV outcomes. The abstract gives no pooled effect sizes or confidence intervals.
  • Substantial heterogeneity and risk of bias across studies were major limitations, and the authors discuss methodological and clinical considerations for future research.
PubMed indexed 16 Jun 2026 Imported 9 Nov 2026 Bucsea O et al. Publisher Chronic painPediatric
Article Pain Published 17 Jun 2026
Dual-frequency spinal cord stimulation increases responder rates for treatment of neuropathic pain.
AI-generated abstract summary · verify against the original paper
  • Preclinical study combining a computational spinal dorsal horn model with experiments in male spared nerve injury rats.
  • Dual-frequency SCS, delivering two simultaneous frequencies, was compared with conventional single-frequency SCS.
  • Dual-frequency SCS increased responder rates over conventional stimulation, with the best pair (2 Hz:54 Hz or 25 Hz:40 Hz) depending on electrode configuration and level, and rodent responder rates reaching 100%.
  • The authors conclude that dual-frequency SCS is a promising way to improve SCS efficacy for neuropathic pain.
PubMed indexed 16 Jun 2026 Imported 9 Nov 2026 Lambert KM et al. Publisher Chronic pain
Article Pain Published 16 Jun 2026
Sexually dimorphic mediation of experimental post-traumatic headache by orexin receptor signaling.
AI-generated abstract summary · verify against the original paper
  • Preclinical mouse study of both sexes after mild traumatic brain injury, using cephalic allodynia as a surrogate for acute and persistent post-traumatic headache.
  • Interventions were supradural orexin B, trigeminal OX2R gene editing by CRISPR/Cas9, and daily oral suvorexant, a dual orexin receptor antagonist.
  • Subthreshold orexin B induced persistent headache-like allodynia only in male mice, and OX2R editing prevented it selectively in males.
  • Suvorexant prevented acute and persistent allodynia, including when started after acute resolution, without disrupting sleep architecture; the authors suggest DORAs may help men.
PubMed indexed 16 Jun 2026 Imported 9 Nov 2026 Lillo Vizin RC et al. Publisher Chronic painNeuro
Article Pain Published 16 Jun 2026
Explainable machine learning on resting-state magnetoencephalography power spectra reveals neural alterations in knee osteoarthritis.
AI-generated abstract summary · verify against the original paper
  • A case-control study compared resting-state MEG recordings from 80 knee osteoarthritis patients with 80 age- and sex-matched healthy controls.
  • Relative power in theta, alpha, beta, and gamma bands, plus peak alpha frequency, was extracted by region and fed to eight machine learning classifiers.
  • KOA patients had reduced theta power in 3 regions and increased gamma power in 5 regions (FDR-P < 0.05); logistic regression reached AUC 0.803 and accuracy 0.770.
  • SHAP analysis ranked frontocentral theta and gamma power as most influential, and theta power correlated negatively with pain intensity.
PubMed indexed 16 Jun 2026 Imported 9 Nov 2026 Miao Z et al. Publisher Chronic pain
Article J Pain Published 15 Jun 2026
'Dealing with it in a way that works for you': Adolescent perspectives on defining coping in the context of pediatric chronic Pain.
AI-generated abstract summary · verify against the original paper
  • Qualitative interview study of 21 adolescents aged 14-19 with chronic pain from Canada, the US, and the UK, analyzed with reflexive thematic and content analysis.
  • Adolescents defined coping and gave feedback on the integrative model, a previously proposed framework of motivational, transactional, and biopsychosocial influences on coping.
  • Adolescents described coping as an active, personal, trial-and-error process that may occur with or without awareness, though its outcomes can be negative despite being seen as positive.
  • The authors proposed a new definition of coping and a revised integrative model that adds visual clarity and flexibility to better match adolescents' experiences.
PubMed indexed 15 Jun 2026 Imported 9 Nov 2026 Nabbijohn AN et al. Publisher Chronic painPediatric
Article J Pain Published 13 Jun 2026
Patterns of postoperative opioid dispensing among Medicaid beneficiaries, 2016-2017 and 2021-2022.
AI-generated abstract summary · verify against the original paper
  • This claims-based study compared 24 common surgical procedures in Medicaid beneficiaries aged 0-64 without cancer, in 2016-2017 and 2021-2022.
  • The exposure was time period, and the study compared procedure-specific opioid dispensing rates, days' supply, and daily MME dosing between the two periods.
  • Dispensing rates fell for every procedure, with ranges of 30.7%-94.5% in 2016-2017 and 8.1%-84.4% in 2021-2022; mean days' supply was also shorter. No CIs or p values are reported.
  • Mean daily dosage decreased for 23 of 24 procedures, and the authors suggest prescribing became more concordant with clinical guidelines, though this is inferred from prescribing patterns.
PubMed indexed 13 Jun 2026 Imported 9 Nov 2026 Shih YW et al. Publisher Chronic painPediatric
Newer Older